Dr. James M. Church, MD

Dr. Church practices at Columbia University Irving Medical Center in New York, New York.

Dr. Church's NPI, 1487698726, was assigned on June 16, 2006. Dr. Church graduated from University of Auckland Faculty of Medicine and Health Sciences in 1973. Dr. Church holds New York license 312219.

Dr. Church's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Church's primary practice is Columbia University Irving Medical Center in New York, New York. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Church to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Church practices. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Church's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dmand AI has Dr. Church's licenses on file in 4 states: New York, Ohio, Illinois and Michigan.

Dmand AI lists colonoscopy among the conditions Dr. Church treats.

CMS data shows 66 Medicare services from Dr. Church across 3 procedure codes in 2021, for 12 Medicare patients. Medicare paid $3,726 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 12 Medicare patients who saw Dr. Church in 2024. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Church's median patient age at 47, with 35% women.

In 2021, Dr. Church wrote 112 Medicare Part D claims. They cover 5 drugs, with $6,675 in total drug cost. In 2020, CMS named 523 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Church for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 347 papers to Dr. Church, published from 2004 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Adenomatous Polyposis Coli, Colorectal Neoplasms and Colonoscopy. Dr. Church has published most often in Dis Colon Rectum. Dr. Church's most frequent co-authors are Matthew F. Kalady, MD, Feza H. Remzi, MD and Tracy L. Hull, MD.

Dmand AI links Dr. Church to 1 clinical trial. Conditions studied include Adenomatous Polyposis Coli and Intestinal Polyposis.

CMS Open Payments shows 27 general payments to Dr. Church from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $1,342.

Dmand AI lists 39 awards for Dr. Church, most recently America's Top Doctors in 2016.

Dr. Church graduated from University of Auckland Faculty of Medicine and Health Sciences in 1973. Dr. Church is a member of ACG, ACS, ASCRS, Collaborative Group of the Americas for hereditary Colorectal Cancer and International Society for Gastrointestinal hereditary Tumors.

Dr. Church is in network with 13 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.